Brigenti Noemi, Gisondi Paolo, Bellinato Francesco, Girolomoni Giampiero
Department of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, Italy.
SAGE Open Med Case Rep. 2024 Feb 27;12:2050313X241235451. doi: 10.1177/2050313X241235451. eCollection 2024.
Generalized pustular psoriasis is defined as a primary, sterile, macroscopically visible pustular eruption on non-acral skin, which can occur with or without systemic inflammation and/or psoriasis vulgaris, and can either be relapsing or be persistent, according to the European Rare and Severe Psoriasis Expert Network. The treatment of generalized pustular psoriasis may be challenging. We describe a 48-year-old woman with a 15-year history of severe generalized pustular psoriasis and plaque psoriasis resistant to multiple courses of treatments with conventional and biological agents who had a rapid, complete and durable (up to 12 months) clinical remission with spesolimab, an anti-interleukin-36 receptor antagonist monoclonal antibody recently approved for the treatment of generalized pustular psoriasis flares.
根据欧洲罕见和严重银屑病专家网络的定义,泛发性脓疱型银屑病被定义为非肢端皮肤出现的原发性、无菌性、肉眼可见的脓疱性皮疹,可伴有或不伴有全身炎症和/或寻常型银屑病,可呈复发性或持续性。泛发性脓疱型银屑病的治疗可能具有挑战性。我们描述了一名48岁女性,有15年严重泛发性脓疱型银屑病和斑块状银屑病病史,对多种常规和生物制剂治疗疗程均耐药,使用司库奇尤单抗后迅速、完全且持久(长达12个月)临床缓解,司库奇尤单抗是一种抗白细胞介素-36受体拮抗剂单克隆抗体,最近被批准用于治疗泛发性脓疱型银屑病发作。